EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Acute pancreatitis in children with inflammatory bowel disease: Risk factors, clinical course, and prognosis

Adi Anafy iD, Yehoshua Mirkin, Tut Galai, Amir Ben-Tov, Hadar Moran-Lev, Anat Yerushalmy-Feler, Shlomi Cohen, Achiya Z Amir

Journal of Pediatric Gastroenterology and Nutrition · 2024

DOI: 10.1002/jpn3.12279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2024. Verfasst von Adi Anafy und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Pediatric Gastroenterology Institute, Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel. Hauptthemen laut MEDLINE: Pancreatitis, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To characterize the clinical course of acute pancreatitis (AP) in pediatric inflammatory bowel disease (IBD) patients compared to children with AP without IBD and to identify risk factors associated with AP among IBD patients.

Methods

This retrospective, single‐center study compared clinical characteristics of children ( 0.01), all had a mild pancreatitis, and none required invasive intervention. The presumed etiology for AP in all IBD patients was IBD‐related: IBD flare‐up in five, side effects of medications in two, and undetermined in seven. The only risk factor for AP development among IBD patients was IBD‐associated arthritis (23% vs. 3% for IBD‐non‐AP, p = 0.04), while extracolonic Crohn's disease and induction therapy with nutrition were negative risk factors (15% vs. 51%, p = 0.05, and 8% vs. 44%, p = 0.04, respectively). Other parameters, including disease type and medications, were nonsignificant.

Conclusion

The clinical course of AP in pediatric IBD patients is mild. Only IBD‐associated arthritis emerged as a risk factor for the development of AP, while, unexpectedly, IBD medication did not.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreatitisInflammatory Bowel DiseasesHumansMaleFemaleRetrospective StudiesAdolescentRisk FactorsChildPrognosisAcute DiseaseChild, Preschool

Stichwörter der Autor:innen

Crohn's Diseasemedicationpediatriculcerative colitis

Autor:innen und Institutionen

  • The Pediatric Gastroenterology Institute, Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.
  • Tel Aviv University, The Faculty of Medical & Health Sciences, Tel-Aviv, Israel.

ORCID-Profile: Adi Anafy

Förderung

  • None

Zitieren

APA

Anafy, A., Mirkin, Y., Galai, T., Ben-Tov, A., Moran-Lev, H., Yerushalmy-Feler, A., Cohen, S., & Amir, A. Z. (2024). Acute pancreatitis in children with inflammatory bowel disease: Risk factors, clinical course, and prognosis. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.12279

Vancouver

Anafy A, Mirkin Y, Galai T, Ben-Tov A, Moran-Lev H, Yerushalmy-Feler A, et al. Acute pancreatitis in children with inflammatory bowel disease: Risk factors, clinical course, and prognosis. Journal of Pediatric Gastroenterology and Nutrition. 2024. doi:10.1002/jpn3.12279

BibTeX
@article{Anafy2024,
  author = {Anafy, Adi and Mirkin, Yehoshua and Galai, Tut and Ben-Tov, Amir and Moran-Lev, Hadar and Yerushalmy-Feler, Anat and Cohen, Shlomi and Amir, Achiya Z},
  title = {Acute pancreatitis in children with inflammatory bowel disease: Risk factors, clinical course, and prognosis},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2024},
  doi = {10.1002/jpn3.12279}
}
Kostenlos starten →